These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 9829965

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Upregulation of caveolin in multidrug resistant cancer cells: functional implications.
    Lavie Y, Fiucci G, Liscovitch M.
    Adv Drug Deliv Rev; 2001 Jul 28; 49(3):317-23. PubMed ID: 11551402
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Role of caveolin-1 in etoposide resistance development in A549 lung cancer cells.
    Bélanger MM, Gaudreau M, Roussel E, Couet J.
    Cancer Biol Ther; 2004 Oct 28; 3(10):954-9. PubMed ID: 15326378
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of caveolin-1 induces alteration of multidrug resistance in Hs578T breast adenocarcinoma cells.
    Cai C, Chen J.
    Int J Cancer; 2004 Sep 10; 111(4):522-9. PubMed ID: 15239129
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cbl-b inhibits P-gp transporter function by preventing its translocation into caveolae in multiple drug-resistant gastric and breast cancers.
    Zhang Y, Qu X, Teng Y, Li Z, Xu L, Liu J, Ma Y, Fan Y, Li C, Liu S, Wang Z, Hu X, Zhang J, Liu Y.
    Oncotarget; 2015 Mar 30; 6(9):6737-48. PubMed ID: 25788263
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells.
    Burgermeister E, Tencer L, Liscovitch M.
    Oncogene; 2003 Jun 19; 22(25):3888-900. PubMed ID: 12813462
    [Abstract] [Full Text] [Related]

  • 15. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells.
    Liu F, Liu S, He S, Xie Z, Zu X, Jiang Y.
    Oncol Rep; 2010 May 19; 23(5):1469-75. PubMed ID: 20372866
    [Abstract] [Full Text] [Related]

  • 16. PTRF/cavin-1 is essential for multidrug resistance in cancer cells.
    Yi JS, Mun DG, Lee H, Park JS, Lee JW, Lee JS, Kim SJ, Cho BR, Lee SW, Ko YG.
    J Proteome Res; 2013 Feb 01; 12(2):605-14. PubMed ID: 23214712
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signaling.
    Ravid D, Maor S, Werner H, Liscovitch M.
    Oncogene; 2005 Feb 17; 24(8):1338-47. PubMed ID: 15592498
    [Abstract] [Full Text] [Related]

  • 19. Multidrug resistance: a role for cholesterol efflux pathways?
    Liscovitch M, Lavie Y.
    Trends Biochem Sci; 2000 Nov 17; 25(11):530-4. PubMed ID: 11084360
    [Abstract] [Full Text] [Related]

  • 20. P-Glycoprotein is localized in intermediate-density membrane microdomains distinct from classical lipid rafts and caveolar domains.
    Radeva G, Perabo J, Sharom FJ.
    FEBS J; 2005 Oct 17; 272(19):4924-37. PubMed ID: 16176266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.